Rockefeller Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,916
Closed -$2.38M 2308
2019
Q3
$2.38M Buy
23,916
+1,707
+8% +$162K 0.03% 267
2019
Q2
$2.05M Sell
22,209
-3,775
-15% -$358K 0.03% 249
2019
Q1
$2.45M Sell
25,984
-16,343
-39% -$1.43M 0.03% 232
2018
Q4
$2.71M Buy
42,327
+430
+1% +$31.7K 0.05% 160
2018
Q3
$3.75M Sell
41,897
-339
-0.8% -$30K 0.06% 135
2018
Q2
$3.35M Buy
42,236
+779
+2% +$64.7K 0.05% 143
2018
Q1
$3.7M Buy
+41,457
New +$3.98M 0.06% 147

Other funds holding CELG

Rockefeller Capital Management's CELG Position: Q4 2019 in Review

Rockefeller Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,916 shares — an estimated $2.38M sold.

Rockefeller Capital Management first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $3.75M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Rockefeller Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Rockefeller Capital Management sold 23,916 Celgene Corp shares in Q4 2019, an estimated $2.38M.
  • Rockefeller Capital Management first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Rockefeller Capital Management's Celgene Corp position peaked at $3.75M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Rockefeller Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.